MXPA03003077A - Novel therapeutic compositions for treating infection by lawsonia spp. - Google Patents

Novel therapeutic compositions for treating infection by lawsonia spp.

Info

Publication number
MXPA03003077A
MXPA03003077A MXPA03003077A MXPA03003077A MXPA03003077A MX PA03003077 A MXPA03003077 A MX PA03003077A MX PA03003077 A MXPA03003077 A MX PA03003077A MX PA03003077 A MXPA03003077 A MX PA03003077A MX PA03003077 A MXPA03003077 A MX PA03003077A
Authority
MX
Mexico
Prior art keywords
therapeutic compositions
novel therapeutic
treating infection
lawsonia spp
lawsonia
Prior art date
Application number
MXPA03003077A
Other languages
Spanish (es)
Inventor
Everett Lee Rosey
Original Assignee
Agriculture Victoria Serv Pty
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR1381A external-priority patent/AUPR138100A0/en
Application filed by Agriculture Victoria Serv Pty filed Critical Agriculture Victoria Serv Pty
Publication of MXPA03003077A publication Critical patent/MXPA03003077A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MXPA03003077A 2000-11-10 2001-11-09 Novel therapeutic compositions for treating infection by lawsonia spp. MXPA03003077A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR1381A AUPR138100A0 (en) 2000-11-10 2000-11-10 Novel therapeutic compositions for treating infection by lawsonia spp
US24959600P 2000-11-17 2000-11-17
PCT/AU2001/001462 WO2002038594A1 (en) 2000-11-10 2001-11-09 Novel therapeutic compositions for treating infection by lawsonia spp

Publications (1)

Publication Number Publication Date
MXPA03003077A true MXPA03003077A (en) 2003-09-25

Family

ID=25646507

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003077A MXPA03003077A (en) 2000-11-10 2001-11-09 Novel therapeutic compositions for treating infection by lawsonia spp.

Country Status (7)

Country Link
EP (1) EP1332154A4 (en)
JP (1) JP2004512851A (en)
BR (1) BR0114835A (en)
CA (1) CA2399276A1 (en)
MX (1) MXPA03003077A (en)
NZ (1) NZ520600A (en)
WO (1) WO2002038594A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004033631A2 (en) * 2002-10-04 2004-04-22 Regents Of The University Of Minnesota Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
FR2980213B1 (en) * 2011-09-16 2013-09-06 Biomerieux Sa PROCESS FOR CHARACTERIZING BACTERIA BY DETECTION OF NON-STRUCTURAL PROTEINS OF BACTERIOPHAGES
US9359643B2 (en) 2013-03-08 2016-06-07 Progenika Biopharma S.A. Discrimination of blood type variants
CL2017002196A1 (en) * 2017-08-30 2017-11-17 Univ De Concepción Recombinant vaccine against proliferative enteropathy in animals.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
NZ322398A (en) * 1995-11-30 2000-02-28 Pig Res & Dev Corp Vaccine compositions comprising non-pathogenic form of Lawsonia intracellularis, nucleic acid sequences thereof and treatment of intestinal disease
AU4260099A (en) * 1998-05-12 1999-11-29 Smithkline Beecham Biologicals (Sa) Compounds from moraxella catarrhalis
TWI224107B (en) * 1998-10-22 2004-11-21 Pfizer Prod Inc Novel proteins from actinobacillus pleuropneumoniae
GB9902880D0 (en) * 1999-02-09 1999-03-31 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
WO2002038594A9 (en) 2002-11-07
CA2399276A1 (en) 2002-05-16
JP2004512851A (en) 2004-04-30
NZ520600A (en) 2004-08-27
WO2002038594A1 (en) 2002-05-16
EP1332154A4 (en) 2005-05-11
BR0114835A (en) 2003-07-01
EP1332154A1 (en) 2003-08-06

Similar Documents

Publication Publication Date Title
MXPA03003168A (en) Topical antibiotic composition for treatment of eye infection.
MXPA03008961A (en) Vaccine composition.
MXPA03000081A (en) Water treatment compositions.
MXPA02011598A (en) Radiolucent aiming guide.
GB0512558D0 (en) Microorganisms for well treatment
GB0128851D0 (en) Fabric treatment compositions
HUP0105379A3 (en) Lawsonia intracellularis vaccine
EG25829A (en) Novel treatment
MX233159B (en) Fabric treatment composition.
HUP0400609A3 (en) Wet-skin treatment compositions
HK1061026A1 (en) 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds
GB0030845D0 (en) Novel treatment
MXPA03003077A (en) Novel therapeutic compositions for treating infection by lawsonia spp.
MXPA03007314A (en) Improved skin composition.
ZA200105597B (en) Antibacterial composition.
AUPR138100A0 (en) Novel therapeutic compositions for treating infection by lawsonia spp
ZA200403323B (en) Anthelmintic composition.
MXPA03009209A (en) 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds.
WO2002010164A3 (en) Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
HK1046848A1 (en) Specific therapeutic composition for treating aids
HK1065816A1 (en) Improvements relating to colour-safe fabric treatment compositions.
GB0114540D0 (en) Laundry treatment composition
GB0030956D0 (en) Stain treatment composition
GB0007659D0 (en) Laundry treatment compositions
GB0029125D0 (en) Novel treatment